Skip to main content
Title
AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.
Summary of Original Version
Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist.
Documents
Introduced .pdf (48.08 KB)
Index Headings of Original Version
Opioid antagonist, overdose reversal
Opioid antagonist, overdose reversal
Opioid antagonist, overdose reversal
Opioid antagonist, overdose reversal
Opioid antagonist, overdose reversal
Opioid antagonist, overdose reversal
Actions
01/06/22
  • introduced in Senate
  • to Committee on Committees (S)
01/10/22
  • to Health & Welfare (S)
01/12/22
  • reported favorably, 1st reading, to Calendar